Nanjing Huawe Medicine Technology Group Co., Ltd.

China

 
Total IP 9
Total IP Rank # 171,382
IP Activity Score 1.5/5.0    6
IP Activity Rank # 156,337

Patents

Trademarks

1 0
0 0
8 0
0
 
Last Patent 2022 - Bosutinib 1,3-propanediether dim...
First Patent 2017 - Indoleamine 2,3-dioxygenase inhi...

Latest Inventions, Goods, Services

2021 Invention Bosutinib 1,3-propanediether dimer impurity and preparation method therefor. Disclosed in the pre...
Invention Pd-l1 cyclic peptide inhibitor containing hydrazide structure. The present invention relates to a...
2020 Invention Apoptosis protein inhibitor, preparation method therefor, and use thereof. The present invention ...
Invention Anti-tumor diazobicyclic apoptosis protein inhibitor. The present invention provides a novel apop...
Invention Antitumor compound used as axl inhibitor and use thereof. Disclosed are a compound as represented...
2018 Invention Indoleamine 2,3-dioxygenase inhibitor, method for preparation and use thereof. A novel indoleamin...
Invention Indoleamine 2,3-dioxygenase inhibitor, preparation method thereof and use thereof. 12344 are as s...
2017 Invention New type indoleamine 2,3-dioxygenase inhibitor. Provided in the present invention are a new type ...
Invention Indoleamine 2,3-dioxygenase inhibitor containing hydrazino group. The present invention provides ...